Acquisition - November 11, 2020
Novo Nordisk to acquire Emisphere Technologies for USD 1.8 billion
Novo Nordisk has entered into a definitive agreement to acquire Emisphere Technologies, a drug delivery company with technologies such as the Eligen SNAC technology, that enable oral formulations of therapeutics. Novo Nordisk and Emisphere have collaborated since 2007 and Emisphere’s drug delivery technology Eligen SNAC is used by Novo Nordisk under an existing licence agreement […]
Acquisition - November 9, 2020
MercachemSyncom acquires Admescope
The European drug-discovery contract research organization MercachemSyncom has acquired Admescope, based in Oulu, Finland and Södertälje, Sweden. The acquisition will give MercachemSyncom expanded capabilities for tailor-made in vitro and in vivo ADME-Tox studies for pre-clinical and early clinical R&D projects and integration with the existing medicinal, synthetic and development chemistry capabilities of MercachemSyncom. Admescope brings […]
Acquisition - October 5, 2020
PledPharma to acquire Rare Thyroid Therapeutics
PledPharma has entered into an agreement to acquire all outstanding shares in Rare Thyroid Therapeutics International. The purchase price for the shares in RTT consists of a cash purchase price in the amount of 60 MSEK, funded from own cash-in-hand, which will be paid on closing and a share purchase price consisting of 63,773,345 new […]
Acquisition - October 4, 2020
10X Genomics acquires Swedish Cartana
US biotech company 10x Genomics has acquired Stockholm-based Cartana for 425 million SEK. The deal was made for a total of $41.2 million (425 million SEK) which includes a $7 million earnout. Cartana, which is currently located at Karolinska Institutet, will continue to be based in Stockholm. “Our team has been focused on developing In […]
Acquisition - September 25, 2020
LEO Pharma sells portfolio of four products to Cheplapharm
LEO Pharma has announced the sale of a portfolio of four non-core products to Cheplapharm for EUR 300 million. The agreement represents a milestone in the roll-out of LEO Pharma’s 2030 strategy which increases the company’s focus on new innovative solutions for medical dermatology, it states. Read more: LEO Pharma’s 2030 strategy might to lead […]
Acquisition - September 21, 2020
Symbioteq acquires Key2Compliance
Medical device QA/RA specialist company Symbioteq has acquired Key2Compliance, specialized in knowledge and information about CGMP and Quality Systems to the life science industry. Both Symbioteq and Key2Compliance were founded in the 1990’s by Tomas Camnell and Anna Lundén, and they will both remain in the new company. The new company will take the name […]
